BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21270668)

  • 21. Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases.
    Monetti F; Casanova S; Grasso A; Cafferata MA; Ardizzoni A; Neumaier CE
    Lung Cancer; 2004 Jan; 43(1):71-4. PubMed ID: 14698539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
    Rusch VW; Gill R; Mitchell A; Naidich D; Rice DC; Pass HI; Kindler HL; De Perrot M; Friedberg J;
    Ann Thorac Surg; 2016 Oct; 102(4):1059-66. PubMed ID: 27596916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: a pilot study.
    Gudmundsson E; Labby Z; Straus CM; Sensakovic WF; Li F; Rose B; Cunliffe A; Kindler HL; Armato SG
    Eur Radiol; 2019 Feb; 29(2):682-688. PubMed ID: 29967955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group.
    Laurie SA; Hao D; Leighl NB; Goffin J; Khomani A; Gupta A; Addison CL; Bane A; Seely J; Filion ML; Pond GR; Levine MN
    Lung Cancer; 2017 Feb; 104():65-69. PubMed ID: 28213002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation.
    Hasan B; Greillier L; Pallis A; Menis J; Gaafar R; Sylvester R; Fennell DA; Baas P; Surmont V; Van Meerbeeck JP; O'brien ME
    Eur J Cancer; 2014 Nov; 50(16):2771-82. PubMed ID: 25155251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.
    Kanemura S; Kuribayashi K; Funaguchi N; Shibata E; Mikami K; Doi H; Kitajima K; Hasegawa S; Nakano T
    Eur J Radiol; 2017 Jan; 86():92-98. PubMed ID: 28027772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?
    Pinelli V; Roca E; Lucchini S; Laroumagne S; Loundou A; Dutau H; Maldonado F; Astoul P
    Respiration; 2015; 89(6):558-64. PubMed ID: 25966972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of patient survival with clinical tumor measurements in malignant pleural mesothelioma.
    Li F; Ahmad M; Qayyum F; Straus CM; MacMahon H; Kindler H; Armato SG
    Eur Radiol; 2019 Jun; 29(6):2981-2988. PubMed ID: 30617480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma.
    Lim JH; Choi JY; Im Y; Yoo H; Jhun BW; Jeong BH; Park HY; Lee K; Kim H; Kwon OJ; Han J; Ahn MJ; Kim J; Um SW
    PLoS One; 2020; 15(2):e0229299. PubMed ID: 32069313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
    Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
    Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study.
    Gill RR; Naidich DP; Mitchell A; Ginsberg M; Erasmus J; Armato SG; Straus C; Katz S; Patios D; Richards WG; Rusch VW;
    J Thorac Oncol; 2016 Aug; 11(8):1335-1344. PubMed ID: 27180318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staging and response to therapy of malignant pleural mesothelioma.
    Heelan R
    Lung Cancer; 2004 Aug; 45 Suppl 1():S59-61. PubMed ID: 15261435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Commentary: Assessing tumor stage and treatment response in pleural mesothelioma: Are pleural thickness measurements the new standard?
    Rusch VW
    J Thorac Cardiovasc Surg; 2023 Aug; 166(2):372-373. PubMed ID: 36732146
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma.
    Lopci E; Zucali PA; Ceresoli GL; Perrino M; Giordano L; Gianoncelli L; Lorenzi E; Gemelli M; Santoro A; Chiti A
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):667-75. PubMed ID: 25403555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of response classification criteria for patients with malignant pleural mesothelioma.
    Labby ZE; Armato SG; Kindler HL; Dignam JJ; Hasani A; Nowak AK
    J Thorac Oncol; 2012 Nov; 7(11):1728-34. PubMed ID: 23059782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical importance of magnetic resonance imaging versus computed tomography in malignant pleural mesothelioma.
    Knuuttila A; Halme M; Kivisaari L; Kivisaari A; Salo J; Mattson K
    Lung Cancer; 1998 Dec; 22(3):215-25. PubMed ID: 10048474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer-aided volumetric assessment of malignant pleural mesothelioma on CT using a random walk-based method.
    Chen M; Helm E; Joshi N; Gleeson F; Brady M
    Int J Comput Assist Radiol Surg; 2017 Apr; 12(4):529-538. PubMed ID: 28028655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. eComment: What is the best way to diagnose and stage malignant pleural mesothelioma?
    Cafarotti S; Porziella V; Margaritora S; Granone P
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):811. PubMed ID: 21555444
    [No Abstract]   [Full Text] [Related]  

  • 39. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases.
    Metintas M; Ucgun I; Elbek O; Erginel S; Metintas S; Kolsuz M; Harmanci E; Alatas F; Hillerdal G; Ozkan R; Kaya T
    Eur J Radiol; 2002 Jan; 41(1):1-9. PubMed ID: 11750145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomographic findings of environmental asbestos-related malignant pleural mesothelioma.
    Yilmaz UM; Utkaner G; Yalniz E; Kumcuoglu Z
    Respirology; 1998 Mar; 3(1):33-8. PubMed ID: 9657657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.